fluconazole has been researched along with epiglucan in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, K; Horiike, S; Kashima, K; Kuzuyama, Y; Misawa, S; Nakai, H; Seryu, T; Takashima, T; Taniwaki, M; Tsuda, S | 1 |
| Kusanagi, H; Shimura, T; Teramoto, A | 1 |
| Maesaki, S; Yamaguchi, T | 1 |
| Imamura, Y; Kakehashi, M; Kouyama, M; Morifuji, M; Murakami, Y; Ohge, H; Sasaki, M; Sueda, T; Takesue, Y; Yokoyama, T; Yokoyama, Y | 1 |
| Naito, Y | 1 |
| Takesue, Y | 1 |
| Andes, D; Hoff, B; Holoyda, K; Lincoln, L; Marchillo, K; Massey, R; Nett, J; VanHandel, M | 1 |
| Pendrak, ML; Roberts, DD; Rodrigues, RG | 1 |
| del Palacio, A; Moragues, MD; Pazos, C; Pontón, J; Quindós, G | 1 |
| Iishii, K; Inami, N; Kimura, E; Nomura, S; Urase, F | 1 |
| Igarashi, K; Kaizaki, Y; Kojima, T; Nakaya, J; Nakaya, T; Takase, K; Yamaguchi, W | 1 |
| Agarwala, SD; Fink, GR; Kombe, D; Wheeler, RT | 1 |
| Imamura, Y; Izumikawa, K; Kohno, S | 1 |
| d'Enfert, C; Rossignol, T; Vediyappan, G | 1 |
| Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA | 1 |
| Andes, DR; Cain, MT; Nett, JE; Ross, KM; Sanchez, H | 1 |
| Katayama, N; Kohara, T; Kyo, T; Nakase, K; Sugawara, Y; Suzuki, K | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Wiederhold, NP | 1 |
| Daniels, KJ; Pujol, C; Sahni, N; Soll, DR; Srikantha, T; Yi, S | 1 |
| Bretagne, S; Chartier, L; Desnos-Ollivier, M; Fontanet, A; Lefort, A; Lortholary, O; Mainardi, JL; Podglajen, I; Sendid, B; Wolff, M | 1 |
| Luo, Z; Qiu, G; Zhang, Y; Zhao, D | 1 |
| Jiang, W; Li, X; Liu, Y; Qiu, X; Wu, N; Yang, X; Zhang, F | 1 |
| Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA | 1 |
| Capilla, J; Guarro, J; Martin-Vicente, A; Sanchis, M | 1 |
| Ardizzoni, A; Blasi, E; Cermelli, C; Colombari, B; Conti, S; Lupetti, A; Magliani, W; Paulone, S; Peppoloni, S; Pericolini, E; Piccinelli, S; Polonelli, L; Posteraro, B; Rizzato, C; Tavanti, A | 1 |
| Brown, M; Goldfarb, I; Johnson, T; Saling, C; Slim, J; Szabela, M | 1 |
| Aimanianda, V; Bardashova, AV; Baykov, IK; Emelyanova, LA; Karelin, AA; Khlusevich, YA; Krylov, VB; Latgé, JP; Matveev, AL; Nifantiev, NE; Tikunova, NV; Tsvetkov, YE; Wong, SSW; Yashunsky, DV | 1 |
| Alteri, C; Bielli, A; Brioschi, P; Cairoli, R; Cento, V; Colombo, J; De Gasperi, A; Gasparini, LE; Gatti, M; Lepera, V; Lombardi, G; Mancini, V; Mazza, E; Merli, M; Moioli, MC; Orcese, CA; Perno, CF; Puoti, M; Torri, S; Vismara, C | 1 |
5 review(s) available for fluconazole and epiglucan
| Article | Year |
|---|---|
[Candidiasis].
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Candidiasis; Diagnosis, Differential; Echinocandins; Fluconazole; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Molecular Diagnostic Techniques; Peptides, Cyclic; Prognosis; Serologic Tests | 2003 |
[Emergent mycoses].
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biomarkers; Disease Progression; Fatal Outcome; Fluconazole; Glucans; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Otorhinolaryngologic Diseases; Risk Factors | 2004 |
[Strategy for the treatment of fungal infections in critically ill surgical patients].
Topics: beta-Glucans; Candidiasis; Critical Illness; Fluconazole; Humans | 2004 |
[Candidiasis].
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; beta-Glucans; Biomarkers; Candida; Candidiasis; Diabetes Complications; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Proteoglycans | 2008 |
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome | 2011 |
2 trial(s) available for fluconazole and epiglucan
| Article | Year |
|---|---|
[The usefulness of fluconazole administration and beta-D-glucan measurement in neurosurgical patients with deep-seated mycosis].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; beta-Glucans; Biomarkers; Central Nervous System Fungal Infections; Fluconazole; Glucans; Humans; Middle Aged | 2000 |
Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Aplastic; Antibodies, Fungal; Antibody Specificity; Antifungal Agents; Antigens, Fungal; beta-Glucans; Candida albicans; Candidiasis; False Positive Reactions; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Hepatitis; Humans; Liposomes; Male; Middle Aged; Neutropenia; Patient Isolation; Predictive Value of Tests; Sensitivity and Specificity | 2006 |
21 other study(ies) available for fluconazole and epiglucan
| Article | Year |
|---|---|
[Efficacy of fluconazole on systemic mycosis associated with hematologic malignancies and a study on diagnostic value of plasma beta-D-glucan levels].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Glucans; Biomarkers; Drug Evaluation; Female; Fluconazole; Glucans; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mycoses | 1993 |
Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; beta-Glucans; Candidiasis; Female; Fluconazole; Glucans; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Selection; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Treatment Outcome | 2004 |
Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Glucan 1,3-beta-Glucosidase; Microbial Sensitivity Tests | 2007 |
Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Topics: Aminoglycosides; Antifungal Agents; beta-Glucans; Candida albicans; Caspofungin; Echinocandins; Fluconazole; Fungal Proteins; Genetic Complementation Test; Glucan Endo-1,3-beta-D-Glucosidase; Integrin alpha5beta1; Lipopeptides; Macromolecular Substances; Mutation; Peptide Hydrolases; Peptides, Cyclic | 2007 |
Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Biomarkers; Candidiasis; Cell Adhesion Molecules; Chemokines; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Organophosphates; Platelet Activation; Prodrugs | 2007 |
[Case of pulmonary coccidioidomycosis presented with multiple infiltrative opacities].
Topics: Antifungal Agents; beta-Glucans; Biomarkers; California; Coccidioidomycosis; Eosinophils; Fluconazole; Humans; Immunoglobulin E; Leukocyte Count; Lung Diseases, Fungal; Male; Middle Aged; Radiography, Thoracic; Severity of Illness Index; Thoracic Surgery, Video-Assisted; Travel | 2008 |
Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Topics: Animals; Antifungal Agents; beta-Glucans; Candida albicans; Candidiasis; Caspofungin; Cell Wall; Disease Models, Animal; Echinocandins; Epitopes; Female; Fluconazole; Host-Pathogen Interactions; Hyphae; Lectins, C-Type; Lipopeptides; Membrane Proteins; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Mutation; Nerve Tissue Proteins; Receptors, Immunologic | 2008 |
Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracellular Matrix Proteins; Fluconazole; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Lipopeptides; Luciferases; Membrane Glycoproteins; Transcription, Genetic | 2010 |
Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.
Topics: Animals; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Candidiasis; Catheters; Cell Wall; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Gene Knockout Techniques; Glucosyltransferases; Mice; Protein Kinase C; Rats; Virulence | 2011 |
Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; beta-Glucans; Echinocandins; Female; Fluconazole; Fungemia; Hematologic Diseases; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Miconazole; Middle Aged; Proteoglycans; Retrospective Studies; Treatment Outcome; Trichosporon; Young Adult | 2012 |
Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Blood; Blood Chemical Analysis; Candida albicans; Candidiasis, Invasive; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Mice; Mice, Inbred ICR; Neutropenia; Proteoglycans; Survival Analysis; Treatment Outcome | 2012 |
Nonsex genes in the mating type locus of Candida albicans play roles in a/α biofilm formation, including impermeability and fluconazole resistance.
Topics: beta-Glucans; Biofilms; Candida albicans; Cell Membrane Permeability; Drug Resistance, Fungal; Fluconazole; Gene Deletion; Gene Expression Regulation, Fungal; Genes, Mating Type, Fungal; Genetic Loci; Genotype; Organisms, Genetically Modified; Reproduction, Asexual | 2012 |
Diagnosis, management and outcome of Candida endocarditis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aortic Valve; beta-Glucans; Candida; Candidiasis; Child; DNA, Fungal; Endocarditis; Female; Fluconazole; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proteoglycans; Risk Factors; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2012 |
Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
Topics: beta-Glucans; Biomarkers; Blood Platelets; Case-Control Studies; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Male; Mean Platelet Volume; Mycoses; Platelet Count; Prognosis; ROC Curve; Sensitivity and Specificity; Sepsis | 2015 |
Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis.
Topics: Acute Disease; Animals; beta-Glucans; Colitis; Colon; Cytokines; Dextran Sulfate; Discriminant Analysis; Disease Models, Animal; Fluconazole; Fungi; Inflammation; Intestinal Mucosa; Least-Squares Analysis; Lymph Nodes; Mice; Mice, Inbred C57BL; Occludin; Proteoglycans; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 18S; Spleen; Zonula Occludens-1 Protein | 2015 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole | 2015 |
Antifungal therapies in murine infections by Candida kefyr.
Topics: Amphotericin B; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis, Invasive; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Microbial Viability; Proteoglycans; Survival Analysis; Treatment Outcome | 2016 |
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.
Topics: Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Cell Membrane; Fluconazole; Microbial Sensitivity Tests; Oxidative Stress; Peptides; Permeability; Proteoglycans; Single-Chain Antibodies | 2017 |
(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
Topics: Aged; Antifungal Agents; beta-Glucans; Biomarkers; Candida glabrata; Candidiasis; Drug Monitoring; Endocarditis; Female; Fluconazole; Humans; Predictive Value of Tests; Proteoglycans; Time Factors; Treatment Outcome | 2017 |
Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Antigens, Fungal; Aspergillus fumigatus; beta-Glucans; Candida albicans; Candidiasis; Cell Wall; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Fluconazole; Humans; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2019 |
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Topics: Aged; Antifungal Agents; beta-Glucans; Caspofungin; Diagnostic Tests, Routine; Female; Fluconazole; Humans; Intensive Care Units; Invasive Fungal Infections; Limit of Detection; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Voriconazole | 2020 |